Track the IDX share price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, IDX has logged 8 public disclosures. Market capitalisation: €15.7m. The latest transaction was disclosed on 4 September 2026 (Change in Substantial Holding). Among the most active insiders: Date of change. All data is openly available.
8
Insider Decl.
n/a
Thresholds
€58,971
2 ops.
Buy Volume
n/a
n/a
Sell Volume
44Σ signal
Buys €58,971n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,554 of 29,063 companies
9.1
score / 100
Value
9
Quality
9
FCF yld-22%
Earn yld-24%
EV/EBITDA·
ROE-250%
Gross mgn-0.0%
Net mgn-0.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
IDX es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el XASX. Se enfoca en desarrollar soluciones innovadoras para mejorar la atención médica.